Last Updated: July 27, 2026

TRIPROLIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Triprolidine, and when can generic versions of Triprolidine launch?

Triprolidine is a drug marketed by Watson Labs, West Ward, Kv Pharm, Cenci, Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, Ivax Sub Teva Pharms, Superpharm, and Wockhardt. and is included in thirteen NDAs.

The generic ingredient in TRIPROLIDINE is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TRIPROLIDINE?
  • What are the global sales for TRIPROLIDINE?
  • What is Average Wholesale Price for TRIPROLIDINE?
Summary for TRIPROLIDINE
US Patents:0
Applicants:11
NDAs:13
Drug Prices: Drug price information for TRIPROLIDINE
DailyMed Link:TRIPROLIDINE at DailyMed

US Patents and Regulatory Information for TRIPROLIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIPROLIDINE AND PSEUDOEPHEDRINE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088318-002 Jan 13, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Halsey TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 088735-001 Jan 17, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Kv Pharm TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 072758-001 Nov 25, 1991 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.